Find a Commonwealth Resource
Avelumab
HealthData.Gov
Updated Jul 6, 2026
About this dataset
BAVENCIO (avelumab) is a prescription monoclonal antibody used in immunotherapy to treat certain cancers by blocking PD-L1, helping the immune system fight tumor cells. It's given as an intravenous infusion at a strength of 20 mg/mL. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Avelumab
Access the FDA dataset for Avelumab — ANDA 203308 submitted by Mylan Institutional LLC
Modified Mar 23, 2026